Literature DB >> 8604702

Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.

S Bergman1, B O Key, K A Kirk, D G Warnock, S G Rostant.   

Abstract

The incidence of treated end-stage renal disease (ESRD) in the United States is four times more frequent in African-Americans (AAs) than in whites. This is explained neither by a greater prevalence of hypertension and diabetes mellitus nor by socioeconomic issues. To investigate familial risk of renal disease in AAs, we examined the records of 472 AA dialysis patients in Jefferson County, Alabama. Applying strict criteria, we identified 85 index cases of ESRD associated only with hypertension (H-ESRD). We examined the records of 75 index cases and studied the first-degree relatives of 40 patients. The numbers of men and women with H-ESRD were similar (38 and 37, respectively). There was no statistical difference in age at the onset of dialysis (women 53.7 +/- 13.5 years [+/-SD] and men 49.2 +/- 12.2 years; P = 0.0863). We found evidence for renal disease in 26 of 40 (65%) index cases with participating families. Hypertension was present in all 40 families (100%) and diabetes mellitus was present in 24 families (60%). Eighteen of the 75 H-ESRD index patients had a first-degree relative with ESRD. In total, we found evidence for renal disease in 35 of 75 (47%) We conclude that there is a strong concordance of renal disease in the families of AAs with H-ESRD.

Entities:  

Mesh:

Year:  1996        PMID: 8604702     DOI: 10.1016/s0272-6386(96)90356-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  28 in total

1.  Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD.

Authors:  William M McClellan; David G Warnock; Suzanne Judd; Paul Muntner; Rachel E Patzer; Brian D Bradbury; Leslie A McClure; Britt B Newsome; George Howard
Journal:  Am J Kidney Dis       Date:  2011-11-10       Impact factor: 8.860

Review 2.  Genetics of the kidney and hypertension.

Authors:  Bracie Watson
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

3.  Screening and prevention of chronic kidney disease.

Authors:  Errol D Crook; David O Washington; John M Flack
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

Review 4.  The spectrum of MYH9-associated nephropathy.

Authors:  Meredith A Bostrom; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

5.  Genetic basis of nondiabetic end-stage renal disease.

Authors:  Barry I Freedman; Rulan S Parekh; W H Linda Kao
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

6.  A Case-Based Analysis of Whether Living Related Donors Listed for Transplant Share ESRD Causes with Their Recipients.

Authors:  Arthur J Matas; Rebecca E Hays; Hassan N Ibrahim
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-01       Impact factor: 8.237

7.  A study of renal outcomes in African American living kidney donors.

Authors:  Joseph M Nogueira; Matthew R Weir; Stephen Jacobs; Abdolreza Haririan; Denyse Breault; David Klassen; Deb Evans; Stephen T Bartlett; Matthew Cooper
Journal:  Transplantation       Date:  2009-12-27       Impact factor: 4.939

Review 8.  Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence.

Authors:  P August; B Leventhal; M Suthanthiran
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

9.  Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.

Authors:  Elizabeth I Anyaegbu; Andrey S Shaw; Keith A Hruska; Sanjay Jain
Journal:  Pediatr Nephrol       Date:  2014-12-23       Impact factor: 3.714

Review 10.  Genetics of diabetes complications.

Authors:  Donald W Bowden
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.